Latest Quintiles Stories

NASDAQ: CRME   TSX: COM VANCOUVER, Feb. 4, 2013 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced the selection of Quintiles to provide comprehensive post-marketing lifecycle safety and global regulatory affairs services for BRINAVESS(TM). Quintiles, the world's leading provider of biopharmaceutical services, will begin providing these services effective immediately as Cardiome continues to prepare for the anticipated transfer of BRINAVESS(TM) from...

ALBANY, New York, January 17, 2013 /PRNewswire/ -- According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "Healthcare Contract Research Outsourcing Market (Contract Research Organizations, Clinical Data Management, Clinical Trial Laboratories, Regulatory Medical Writing, Academic Medical Center) - Global Industry Analysis, Size, Share, Trends and Forecast, 2012 - 2018...

ATLANTA, Dec. 4, 2012 /PRNewswire/ -- Alimera Sciences, Inc., (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced it has signed a Master Services Agreement with Quintiles Commercial Europe Ltd. (Quintiles) for the commercial launch of ILUVIEN(® )in certain European countries. ILUVIEN is Alimera's product for the treatment of chronic diabetic macular...

WOODCLIFF LAKE, N.J. and FORT WORTH, Texas, Sept. 28, 2012 /PRNewswire/ -- Par Pharmaceutical Companies, Inc., and TPG today announced the completion of Par's acquisition by certain affiliates of TPG. "This transaction has delivered significant value to our shareholders and is a strong endorsement of our business model, our team, and our unique position in the generic industry," said Patrick G. LePore, Par's Chairman of the Board. "As a private company, Par will have greater...

Xtalks presents a live webinar on September 24, 2012 at 11:00am EDT. Join our panel, Eleanor A. Lisbon MD, MPH, CPI, Director, Senior Medical Services, Quintiles, Professor Tim Mant, Principal Investigator, Quintiles, Steve Lowes, PhD, Vice President, Scientific, Advion Bioanalytical Labs, A Quintiles Company, and N. Seth Berry, PharmD, Director, Clinical PK/PD Modeling & Simulation, Quintiles Innovation, and as they examine steps to improve your dose selection and ultimately the value...

Workshop was focussed on the role of imaging core labs in the clinical trials space. Bangalore, India (PRWEB) August 31, 2012 Image Core Lab in collaboration with Teleradiology Solutions and the DIA hosted a unique and innovative one day workshop on ‘Imaging in Clinical Trials’ which was focussed on the role of imaging core labs in the clinical trials space. The event took place in Bangalore on the 27th of July and was well received with participants from the pharmaceutical,...

FARMINGTON, Conn., Aug. 22, 2012 /PRNewswire-iReach/ -- It's a well known data point that while the pills a doctor prescribes may cost pennies each to manufacture, the first pill cost many millions of dollars to research, develop, test, and certify. Along the way, many routes are pursued and ultimately dropped when they fail to yield marketable results. One way drug manufacturers can lower their costs and increase their output is to outsource stages of the process to Contract...

SAN DIEGO, Aug. 7, 2012 /PRNewswire/ -- Verum.de (Verum), a full-clinical service, German-based contract research organization (CRO) with outstanding experience in Central and Eastern European countries (CEE), has opened a new office in Carlsbad, Calif. The company opened the office to make its clinical trial services more readily available to clients in the U.S. and North America. By conducting clinical trials with Verum in CEE countries, clients will benefit from faster patient...

CARY, N.C., June 20, 2012 /PRNewswire/ -- Cetero Research announced the completion of a major milestone in its reorganization efforts. Following the company filing for reorganization under Chapter 11 and the U.S. District Bankruptcy Court's approval of the sale of Cetero to its investor group, led by Freeport Financial, the sale of the company was finalized on June 20, 2012. (Photo: http://photos.prnewswire.com/prnh/20120620/PH27754 ) Over recent months, Cetero has engaged with...

MESA, Ariz., May 18, 2012 /PRNewswire/ -- On May 15, attorneys at the Arizona law firm of JacksonWhite filed a collective action lawsuit against Quintiles Commercial U.S., Inc., for failure to pay its employees the overtime wages to which they are entitled under the Fair Labor Standards Act (FLSA). The Complaint was filed in the United States District Court for the District of Arizona on behalf of all Quintiles pharmaceutical reps employed in the U.S. from May 2009 until the present....